2394 Sodium-glucose transporter 2 is a novel diagnostic and therapeutic target for early-stage lung adenocarcinoma

OBJECTIVES/SPECIFIC AIMS: Lung cancer claims 160,000 lives in the United States every year, and lung adenocarcinoma (LADC) is the most frequent type. Early diagnosis is crucial. Computed tomography (CT) is very sensitive in identifying early-stage lung nodules, but has low specificity. Increased glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Scafoglio, Claudio, Abdelhady, Gihad, Liu, Jie, Yanagawa, Jane, Wallace, Dean, Barrio, Jorge, Dubinett, Steven, Shackelford, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Basic/Translational Science/Team Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799059/
http://dx.doi.org/10.1017/cts.2018.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799059/
http://dx.doi.org/10.1017/cts.2018.122

Ejemplares similares